National Cancer Institute,
Cancer Centers Program
Downloads  |  FAQ  |  Site Map
Cancer Centers Grants and Funding News and Events About Us

Home > News & Events > Centers Updates

Centers Updates

Reminder: Spring 2008 Cancer Centers Directors Retreat

This is a reminder that the next Cancer Center Directors Retreat will be held at the Hyatt Regency in Bethesda on Sunday and Monday, April 27th and 28th, 2008. As in the past, the meeting will begin at approximately 4 p.m. on the first day and adjourn late in the afternoon the following day. Additional information on meeting logistics and agenda will be forwarded at a later date. —posted 10/15/2007


Use of NCI Logo

The National Cancer Institute (NCI) logo (Figure 1) is a registered trademark that distinctly identifies the NCI. Entities other than the NCI, the National Institutes of Health, or the U.S. Department of Health and Human Services must receive formal approval prior to its use on web sites or in written materials. Unauthorized use of the NCI logo may constitute trademark infringement, as it may suggest NCI sponsorship or endorsement of the policies, products, and services of other institutions.

At present, only the NCI–designated Comprehensive Cancer Center logo (Figure 2) is approved for use by cancer centers that have earned the comprehensive designation through the peer review process.

Any NCI–designated Cancer Center currently using the NCI logo should remove it from all websites and printed materials. The phrase, “National Cancer Institute–designated Cancer Center” may be substituted in place of the NCI logo graphic.

If you have further questions or concerns regarding the use of the NCI logo, please contact:

Donna P. Bonner, MSPM
Publications Support Branch
National Cancer Institute
Telephone: (301) 496–4394 —posted 9/14/2007


Fiscal Year 07 Funding Memo

This memo is to advise you that, in accordance with NIH policy, Fiscal Year 07 non–competing (T5) P30 awards will be funded at approximately 97.1% of the Fiscal Year 06 level. Administrative extensions at the request of the NCI (e.g., as part of the recycling effort) will be funded at that level, as well.

Funding levels for Fiscal Year 07 competing (T1 and T2) and other types of administrative extensions will be communicated individually to applicants, once finalized.

We’d like to extend our thanks for your patience during this extended budget process.

Please contact your program director if you have questions.

Linda K. Weiss, Ph.D.
Cancer Centers Branch
Office of Centers, Training, and Resources
National Cancer Institute
—posted 4/23/2007


Electronic Submission of Summaries 2, 3 and 4

Effective January 5, 2007, the Cancer Centers Branch is eliminating the requirement for hard copy versions of Summaries 2–4 in Type 5 (non–competing) progress reports. Electronic versions of these summaries must still be submitted to our office so that they may be uploaded into the NCI official application file for your center. Summaries 1 a, b, c, and d should continue to be submitted in both hard copy and electronic format.

Please note that this change affects non–competing T5 applications only. Competing Type 2 applications would still require both hard copy and electronic versions of all summaries. If you have any questions about the summaries or their format, please call (301) 496–8531.

—posted 1/5/2007


New P30 Receipt Dates

Please note that, as per the NIH Guide Notice, standing receipt dates for P30 CCSG applications will change effective January 1, 2007. The new receipt dates will be January 25, May 25, and September 25. Inquiries regarding this policy should be directed to the contact office noted in the announcement. —posted 10/10/2006


Special Session on Assessment of Response to Therapy via Imaging Techniques
In 2005, the NCI Cancer Imaging Program and Cancer Centers Branch announced 8 Cancer Centers as awardees of supplements for Imaging Response Assessment Teams (IRATs). A first meeting of awardees, part of which will be open to other interested Center faculty, will be held in March in Orlando in conjunction with the annual meeting of the Academy for Medical Imaging.

As a reminder, the concept of the IRATs grew out of discussions between the Association of American Cancer Institutes and the NCI. IRAT supplemental awards are intended to facilitate the development of a Cancer Center core that will advance the role of imaging in assessment of response to therapy and increase the application of quantitative, anatomic, functional, and molecular imaging endpoints in clinical therapeutic trials. Integration of IRAT team members into the protocol planning process and increasing clinical collaborations between imaging scientists and oncologic investigators is also a goal. When the three year supplemental funding ends, each Center should have a committed shared resource.

The IRAT Network—the IRAT leaders and NCI leaders—and their collaborators will convene for their first workshop, March 24–25, 2006, in Orlando. The workshop will be an affiliate event of the Academy of Molecular Imaging's (AMI) annual conference at the Gaylord Palms Resort and Convention Center, March 25–29. The IRAT workshop will include a special session, Saturday, March 25, 12:00 to 2:00 p.m., that will be open to the greater scientific and cancer center communities interested in and currently working on issues related to the assessment of response to therapy via imaging techniques, and we are encouraging interested scientists from all centers to attend.

Information about the AMI conference may be accessed through their website at For further information about the workshop, please contact Maureen Pfeifer at Maureen@aaci– or (412) 647–6331.

—posted 3/1/2006

The University of New Mexico Cancer Research and Treatment Center Receives NCI Designation

The University of New Mexico Cancer Research and Treatment Center (UNM CRTC) was awarded the NCI designation in September of 2005, making it our 61st cancer center. Dr. Cheryl Willman is the Director of the Center, which is the only NCI–designated cancer center in the state of New Mexico. The Center was previously funded by a five–year NCI P20 Cancer Center Planning Grant. The 91 members of the UNM CRTC are clustered into 4 research programs that include Cancer epidemiology and Prevention, Cancer Biology, Hematologic Malignancies, and Women’s Cancers. Research goals of the Center are focused on New Mexico’s unique ethnic diversity and significant economic and medical disparities, and the opportunities presented by their unique partnerships. —posted 9/1/2005